Akero Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Akero Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Akero Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Akero Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $292k | 10k | 28.69 |
| 2024-06-30 | $1.6M | 70k | 23.46 |
| 2024-03-31 | $2.6M | 103k | 25.26 |
| 2023-12-31 | $234k | 10k | 23.35 |
| 2023-09-30 | $914k | 18k | 50.58 |
| 2023-06-30 | $1.1M | 24k | 46.69 |
| 2022-09-30 | $2.4M | 70k | 34.05 |
| 2022-06-30 | $294k | 31k | 9.46 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management